Even though the scientific relevance from the aforementioned cardiovascular threat factor alterations by tirzepatide will be assessed while in the prepared cardiovascular consequence study SURPASS-CVOT ( "form":"medical-demo","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Evaluatio